LO
Policy mandateCognitive automation2021-11-19
Medicare set a national payment for automated retinal image analysis, saying such technology is substituting for and/or augmenting physician work, in its 2022 fee schedule rule
Optometristoccupation page →
Event date / reported
2021-11-19
Evidence stage
Policy mandateRegulation, subsidy or public procurement is requiring or funding adoption — the mirror of a constraint. It shows adoption is being required, not that it has happened, so one mandate is never enough on its own; two independent ones are.
Tasks this bears on
Spotting eye disease in retinal images
Photographing and reading the back of the eye for signs of diabetic eye disease, glaucoma and macular degeneration.
Automating✓ Evidence-backed
Where this applies
United States. The Medicare rule says some new codes cover services where innovative technology is substituting for and/or augmenting physician work, citing code 92229 for point-of-care automated analysis of retinal images for diabetic retinopathy. After leaving its price to regional contractors for 2021, the agency finalised national payment values for the code. A payment rule funds the service; it does not require anyone to use it.
What this means
The largest US payer now pays a set rate when software reads the retinal images.
What it does not yet show
A payment decision; it does not show how often the code is billed.
What you can check
Open the CY 2022 Physician Fee Schedule final rule (86 FR 64996) and find "substituting for and/or augmenting physician work".
Does it change the assessment?
No. The impact index is never moved by a single event. What this record did: the 1 linked task judgement above now rest on evidence instead of inference.
Source
Centers for Medicare & Medicaid Services — CY 2022 Physician Fee Schedule final rule, 86 FR 64996 (Federal Register, November 19, 2021) · verified 2026-09-30 · Claude (VOLO agent) · interpreted 2026-09-30 · Claude (VOLO agent)
Primary source — published by the party that did this, or the authority of record. No co-signature needed.